Thermo Fisher Scientific Sorvall Legend Centrifuges Preventative Maintenance Services
ID: 25-001314Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Electronic and Precision Equipment Repair and Maintenance (811210)

PSC

MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT (J066)

Original Source

https://sam.gov/opp/b8749aecfdb94fc79a47f303e0a9050f/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Thermo Fisher Scientific for preventative maintenance services on thirty-one Sorvall Legend Centrifuges. The primary objective of this procurement is to ensure the continued operational integrity of critical laboratory equipment used in the manufacturing of cell-based therapies for patients enrolled in clinical trials, adhering to stringent FDA regulations. Given the importance of these centrifuges in supporting patient care and the potential risks associated with transitioning to a new vendor, the NIH emphasizes that only the original equipment manufacturer can perform necessary software updates and maintenance. Interested parties capable of providing similar services must submit a capability statement by November 17, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.

    Point(s) of Contact
    Sheri Eiri
    000000000
    sheri.eiri@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    Preventative Maintenance Contract for NICHD Peptide Synthesizer Equipment
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), through the National Institute of Child Health and Development (NICHD), intends to award a non-competitive purchase order to CEM Corporation for a Preventative Maintenance Contract for its peptide synthesizer equipment. This contract is essential for ensuring the operational efficiency of the synthesizer, which is critical for synthesizing peptides used in structural and biochemical research, particularly in studies related to membrane proteins. CEM Corporation, as the sole manufacturer and distributor of the synthesizer in North America, provides specialized technical support and maintenance services that are vital for the continuity of research capabilities. Interested parties may submit their capabilities electronically by January 2, 2025, although this is not a request for competitive proposals. For further inquiries, contact Jacob M. Balenson at jacob.balenson@nih.gov or call 301-827-8302.
    Notice of Intent to Sole Source – TheraDoc subscription
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) Clinical Center intends to award a firm fixed-price purchase order for subscription services related to the TheraDoc application, exclusively owned by Premier Healthcare LLC. This procurement aims to secure applications, support, maintenance, and training for the TheraDoc clinical surveillance solution, which is critical for enhancing healthcare delivery and patient safety. The acquisition will follow the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a sole-source solicitation due to the unique nature of the services required. Interested parties may express their capabilities and submit comments to the NIH by November 21, 2024, with inquiries directed to Ryssa Nix at Ryssa.nix@nih.gov.
    Central Utility Plant Grid Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure Central Utility Plant Grid Support Services through a sole source contract with ABB, Inc. This contract aims to secure onsite engineering and technical maintenance support for the ABB Distributed Control System (DCS), which is critical for managing the heating and cooling systems across the NIH campus in Research Triangle Park, North Carolina. The necessity for these specialized services arises from the proprietary nature of ABB's software and tools, which require certified technicians for optimal operation, as outlined in FAR 6.302-1. Interested parties are encouraged to express their capabilities by contacting Andrew Gathogo at andrew.gathogo@nih.gov or Amanda Tilton at Amanda.tilton@nih.gov, with the understanding that this notice is not a request for proposals.
    Orbitor RS2 Microplate Robotic Bundle with Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through its National Institute of Allergy and Infectious Diseases (NIAID), intends to procure an Orbitor RS2 Microplate Robotic Bundle with integrated software for its Vaccine Immunology Program (VIP) within the Vaccine Research Center (VRC). This procurement aims to automate the handling and analysis of Mabtech Fluorospot Assays, which are critical for evaluating T-cell responses in clinical trials, thereby enhancing the efficiency and accuracy of vaccine research. The equipment must meet specific technical requirements, including compatibility with existing lab systems and advanced features such as a bi-directional telescoping arm and Momentum™ scheduling software. Interested vendors are invited to submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by January 3, 2025, at 5:00 PM ET, with all submissions considered by the Government at its discretion.
    CALIBRATION AND REPAIR MAINTENANCE AGREEMENT FOR EXISTING EQUIPMENT
    Active
    Health And Human Services, Department Of
    Special Notice: Department of Health and Human Services, National Institutes of Health intends to award a sole source contract to TSI, Inc. for a Calibration and Repair Maintenance Agreement for existing equipment. The vendor will provide calibration and repair service for approximately 130 pieces of TSI and TSI-Quest industrial hygiene and exposure monitoring equipment. This service is typically required on an annual basis and includes the replacement of consumable items, inspection and cleaning of serviceable parts, and repairs by technically qualified personnel. The vendor will also provide a detailed service report and ensure that the calibration service meets or exceeds accuracy standards traceable to the National Institutes for Standards and Technology (NIST). Interested parties must submit capability information by March 14, 2024, to establish their ability to meet this requirement. Contact Ms. Van Holley at holleyv@od.nih.gov for inquiries and submissions.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Preventative Maintenance and Service Package for the Mediso nanoScan PET/CT animal imager
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking qualified vendors to provide a Preventative Maintenance and Service Package for the Mediso NanoScan PET/CT animal imager. This procurement involves a comprehensive service plan that includes a 12-month base period followed by four optional 12-month periods, commencing on February 10, 2025, at the Biomedical Research Center in Baltimore, Maryland. The Mediso NanoScan PET/CT is crucial for advanced imaging in biomedical research, and the selected vendor must demonstrate technical capabilities, customer support, and delivery speed as part of the evaluation process. Interested parties should note that the Request for Quotation (RFQ) number is 75N95025Q00104, with responses due by January 6, 2025. For further inquiries, vendors can contact Andrew Varley at andrew.varley@nih.gov or Joshua T. Lazarus at Josh.Lazarus@nih.gov.
    SOURCES SOUGHT: Automated Cell Dissociation Apparatus
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide an automated cell dissociation apparatus for the National Institute on Aging's Laboratory of Neurogenetics. The primary objective of this procurement is to acquire equipment capable of isolating single nuclei from human and mouse brain tissues, which is crucial for advancing research on neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease. The preferred model for this apparatus is the S2 Genomics Singulator 100 Cell Dissociation Platform, which must meet specific requirements including bench-top compatibility, single-use cartridges, and customizable software for protocol adjustments. Interested companies must submit their capability statements by January 17, 2025, to Rashiid Cummins at rashiid.cummins@nih.gov, ensuring they include all necessary documentation and adhere to the specified format.